Zobrazeno 1 - 10
of 1 324
pro vyhledávání: '"Childhood leukaemia"'
Publikováno v:
EJC Paediatric Oncology, Vol 2, Iss , Pp 100118- (2023)
Background: Bone and joint infections (BJI) are common in immunocompetent children, however in children with acute leukaemia the epidemiology, optimal diagnostic pathway and medical and surgical treatment is poorly described. We review the presentati
Externí odkaz:
https://doaj.org/article/6e566041122f41b8ac90cb2369c36bdb
Autor:
Sabina Enlund, Indranil Sinha, Amanda Ramilo Amor, Shahrzad Shirazi Fard, Ekaterina Pokrovskaja Tamm, Qingfei Jiang, Vanessa Lundin, Anna Nilsson, Frida Holm
Publikováno v:
eJHaem, Vol 4, Iss 1, Pp 115-124 (2023)
Abstract With modern treatment most children with acute lymphoblastic leukemia (ALL) survive without relapse. However, for children who relapse the prognosis is still poor, especially in children with T‐cell phenotype (T‐ALL) and remains the majo
Externí odkaz:
https://doaj.org/article/5deda66b7cfd4c549e5f196698d58ad1
Publikováno v:
Environmental Health, Vol 21, Iss 1, Pp 1-15 (2022)
Abstract Background Domestic and parental occupational pesticide exposures are suspected of involvement in the occurrence of childhood acute leukaemia (AL), but the role of exposure to agricultural activities is little known. In a previous ecological
Externí odkaz:
https://doaj.org/article/afebe3f2c7ae4d59818976f6ceb12feb
Autor:
Mette Tiedemann Skipper, Cecilie Utke Rank, Kirsten Brunsvig Jarvis, Line Stensig Lynggaard, Liv Andrés‐Jensen, Petter Quist‐Paulsen, Ruta Semaskeviciene, Helene Hallböök, Ulla Waitiovaara‐Kautto, Susanna Ranta, Sonata Trakymiene, Jonas Abrahamsson, Pasi Huttunen, Birgitte Klug Albertsen, Kjeld Schmiegelow, Ruta Tuckuviene
Publikováno v:
eJHaem, Vol 3, Iss 3, Pp 754-763 (2022)
Abstract Cerebral sinovenous thrombosis (CSVT) is a serious complication during asparaginase therapy in patients with acute lymphoblastic leukaemia (ALL). We identified 46 patients with CSVT among 2651 patients (1‒45 years) treated according to the
Externí odkaz:
https://doaj.org/article/e2579624e85546efa389e8e30db8350e
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
L-asparaginase, which hydrolyzes asparagine into aspartic acid and ammonia, is frequently used to treat acute lymphoblastic leukaemia in children. When combined with other chemotherapy drugs, the event-free survival rate is 90%. Due to immunogenicity
Externí odkaz:
https://doaj.org/article/0455ad52280f47c499f3877cf49f2b42
Autor:
Karolina Chmielowiec, Gary Beattie, Kathryn Clarke, Ellen McCloy, Bethany Mitchell, Christine Macartney
Publikováno v:
eJHaem, Vol 4, Iss 2, Pp 520-521 (2023)
Externí odkaz:
https://doaj.org/article/bfc5c564b15948cab619a7382598cd59
Autor:
Felix M. Onyije, Ann Olsson, Friederike Erdmann, Corrado Magnani, Eleni Petridou, Jacqueline Clavel, Lucia Miligi, Audrey Bonaventure, Daniela Ferrante, Sara Piro, Susan Peters, Roel Vermeulen, Hans Kromhout, Joachim Schüz
Publikováno v:
Environment International, Vol 167, Iss , Pp 107409- (2022)
Parental occupational exposures around conception (father) or during pregnancy (mother) have been hypothesized as potential predisposing factors for childhood leukaemia. We investigated parental exposure to several known occupational carcinogens and
Externí odkaz:
https://doaj.org/article/51e7806d12454108825a1e4be07ca618
Publikováno v:
Clinical Psychology in Europe, Vol 4, Iss 1 (2022)
[Background] Sex differences are widely reported in clinical psychology but are rarely examined in interventions. [Method] This mixed-method explorative study examined sex differences in 13 mothers and 10 fathers of children in the off-therapy phase
Externí odkaz:
https://doaj.org/article/c4b2186b642c40d2ac00e266ca26d6a6
Publikováno v:
PeerJ, Vol 9, p e11803 (2021)
Background Acute lymphoblastic leukemia (ALL) is the most common type of childhood cancer. It can be caused by mutations that turn on oncogenes or turn off tumour suppressor genes. For instance, changes in certain genes including Rb and p53 are commo
Externí odkaz:
https://doaj.org/article/afabacef035d4f049a27492128346918
Autor:
Treya M. Long, Channa E. Marsh, Lawrence G. Dembo, Philip Watson, Karen E. Wallman, Thomas S. Walwyn, Catherine S. Choong, Louise H. Naylor
Publikováno v:
Cardio-Oncology, Vol 5, Iss 1, Pp 1-10 (2019)
Abstract Background Cardiovascular disease (CVD) is the leading non-malignant cause of death in childhood cancer survivors. Heightened risk of CVD is often attributable to treatment with anthracycline chemotherapy. Anthracycline-mediated cardiac inju
Externí odkaz:
https://doaj.org/article/d1721ae7c6ab4a72a9b1574674f2aeec